TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Interaction Details
01. General Information
Pair Name Magnolin, B-RAF Inhibitors
Phytochemical Name Magnolin (PubChem CID: 169234 )
Anticancer drug Name B-RAF Inhibitors (PubChem CID: 44223999 )
Structure of
Phytochemical
2D-img
Download
2D MOL 3D MOL
Structure of
Anticancer Drug
2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Enhancing Drug Efficacy
Hide/Show
Combination Pair ID: 342
Pair Name Magnolin, B-RAF Inhibitors
Disease Info [ICD-11: 2C12] Hepatocellular carcinoma Investigative
Biological Phenomena Induction-->Blockade of cell cycle in G0/G1 phase
Gene Regulation Down-regulation Expression AKT1 hsa207
Up-regulation Expression BAX hsa581
Down-regulation Expression BCL2 hsa596
Up-regulation Cleavage CASP9 hsa842
Down-regulation Expression CCND1 hsa595
Up-regulation Expression CDKN1A hsa1026
Down-regulation Phosphorylation MAP2K7 hsa5609
Down-regulation Phosphorylation MAPK1 hsa5594
Down-regulation Expression MTOR hsa2475
Up-regulation Cleavage PARP1 hsa142
Down-regulation Expression PIK3CA hsa5290
Up-regulation Expression PSMD9 hsa5715
Down-regulation Phosphorylation RPS6 hsa6194
Down-regulation Phosphorylation RPS6KB1 hsa6198
In Vitro Model BEL-7402 Human papillomavirus-related cervical adenocarcinoma Homo sapiens (Human) CVCL_5492
SK-HEP-1 Liver and intrahepatic bile duct epithelial neoplasm Homo sapiens (Human) CVCL_0525
Result Synergistic activity of magnolin combined with B-RAF inhibitor SB590885 in hepatocellular carcinoma cells via targeting PI3K-AKT/mTOR and ERK MAPK pathway
03. Reference
No. Title Href
1 Synergistic activity of magnolin combined with B-RAF inhibitor SB590885 in hepatocellular carcinoma cells via targeting PI3K-AKT/mTOR and ERK MAPK pathway. Am J Transl Res. 2019 Jun 15;11(6):3816-3824. Click
It has been 26635 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP